Lipid Disorders
Conference Coverage
Which antidiabetic for elderly patients? It depends on their CV risk
Balancing heart failure with cardiovascular events
Conference Coverage
GLP-1 RA dulaglutide yields cardiac gains, even in non–at-risk patients
SAN FRANCISCO – REWIND data show that over roughly 5 years of treatment, patients with type 2 diabetes had a lower risk of MACE.
Conference Coverage
Updated systematic review of aspirin primary prevention shows benefits, risks
Conference Coverage
How to reverse type 2 diabetes with a crash diet: the DiRECT approach
SAN FRANCISCO – A few months of a medically supervised liquid diet; durable remission at 2 years.
From the Journals
Carotid ultrasound may aid cardiovascular risk stratification of patients with psoriatic disease
The study suggests that bedside ultrasound could be a valuable augmentation to traditional risk stratification in these patients.
From the Journals
Lipoprotein(a) levels can guide CV risk assessment and treatment
High levels of Lp(a) are an independent risk factor for atherosclerotic cardiovascular disease and could be used to guide risk assessment and...
News
FDA grants Priority Review to Vascepa for cardiovascular risk reduction
The Food and Drug Administration has granted a Priority Review to the supplemental new drug application for icosapent ethyl (Vascepa).
From the Journals
Coding variants in apolipoprotein B may be associated with early-onset Alzheimer’s disease
The finding may help fill out the genetic risk picture for early-onset Alzheimer’s disease.
Latest News
Revascularization plus exercise is most effective for intermittent claudication
From the Journals
Incidence of adult diabetes drops, prevalence remains stable
Type 2 prevention efforts might be working.
Conference Coverage
Ethnicity seems to affect predisposition to components of metabolic syndrome
SAN DIEGO – The study supports adopting regional anthropometric criteria.